Table PPP-9. Composition of illicit drug tablets, 2008 [see all tables in this series...]

Part (i) Content of synthetic scheduled illicit drugs

Country
		Number of tablets	MDMA-like Substance {as the only scheduled substances}	(Meth)Amphetamine {as the only scheduled substances}	MDMA-like Substance and (Meth)Amphetamine {as the only scheduled substances}	Others {scheduled substances}	Miscellaneous	Total
Belgium	(1)	174	61.5	0.0	0.6	1.7	36.2	100
Bulgaria	(1)	237	60.7	13.1	1.7	0.0	24.5	100
Czech Republic		15	69.0	8.0	15.0	0.0	8.0	100
Denmark		164	82.0	1.0	1.0	14.0	2.0	100
Germany		541727	96.5	0.0	0.0	0.0	3.5	100
Estonia		510	83.0	0.0	5.0	0.0	12.0	100
Ireland		:	:	:	:	:	:	:
Greece		7193	96.0	2.0	1.0	0.0	1.0	100
Spain		1236	34.2	0.0	3.3	3.3	59.2	100
France		64	84.0	8.0	3.0	3.0	2.0	100
Italy	(1)	79	61	7.6	7.6	8.8	15.0	100
Cyprus		8075	11.9	11.1	4.1	1.2	71.7	100
Latvia	(1)	264	33.0	0.0	0.0	0.0	67.0	100
Lithuania		:	:	:	:	:	:	:
Luxembourg		49	36.5	0.0	16.5	8.5	38.5	100
Hungary	(1)	517	66.5	16.1	1.4	0.4	15.6	100
Malta		:	:	:	:	:	:	:
Netherlands		3621	79.0	1.0	1.0	4.0	15.0	100
Austria		146	71.2	0.7	0.0	0.0	28.1	100
Poland		270	74.0	1.5	18.0	6.5	0.0	100
Portugal		274	96.0	0.0	0.0	0.0	4.0	100
Romania		848	68.9	28.1	0.0	0.0	3.0	100
Slovenia		593	47.0	2.0	0.0	20.0	31.0	100
Slovakia		6302	99.9	0.0	0.0	0.0	0.1	100
Finland		172	73.8	0.0	1.2	0.0	25.0	100
Sweden		:	:	:	:	:	:	:
United Kingdom	(1)	2505	51.0	2.0	1.0	1.0	45.0	100
Croatia	(1)	77	43.0	25.8	1.2	0.1	30.1	100
Turkey		10518	77.9	9.1	0.0	0.0	13.0	100
Norway		35350	74.0	4.0	1.0	8.0	13.0	100

Notes:

 The table seeks to monitor synthetic scheduled illicit drugs - i.e. drugs controlled under the 1971 UN Convention on Psychotropic Substances Schedules I and II and under European legislation (Council Decisions), providing data on the contents of illicit drug tablets from different sources (seizures, users' submissions, etc.). 

 (1) This figure "Number of tablets" refers to the total number of records analysed; that is the number of different tablet types analysed. 

 For methodological information: source, sampling frame and type of study, please refer to Table PPP-9 part(ii). and Table PPP-9 part(iii).  

 For additional available information on substances included in categories "Miscellaneous" and "Other", please refer to Table PPP-9 part(iv).  

Sources:

 Reitox national focal points.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)